NCT03107507 Efficacy of Levetiracetam in Control of Neonatal Seizures Guided by an EEG Status UNKNOWN Phase PHASE4
NCT03054285 Does Short-Term Anti-Seizure Prophylaxis After Traumatic Brain Injury Decrease Seizure Rates? Status UNKNOWN Phase PHASE4
NCT03034356 Reducing Hippocampal Hyperactivity and Improving Cognition in Schizophrenia Status COMPLETED Phase PHASE1/PHASE2
NCT02815410 Validation of the Role of Levetiracetam for Newly Diagnosed GBM Patients Status UNKNOWN Phase PHASE2
NCT02726867 Levetiracetam, Lacosamide and Ketamine as Adjunctive Treatment of Refractory Status Epilepticus Status WITHDRAWN Phase PHASE3
NCT02647437 Effects of Low-dose Levetiracetam on Clinical Symptoms, Cognition and Hippocampal Hyperactivity in Schizophrenia Status COMPLETED Phase NA
NCT02603991 Prospective Cohort Study on the Efficacy of Vagus Nerve Stimulation for Children and Adolescents With Epilepsy(PVNS-CAE) Status UNKNOWN Phase N/A
NCT02602860 A Brain Imaging Study With Positron Emission Tomography and the Radiotracer [11C]UCB-J to Estimate How Fast Brivaracetam and Levetiracetam Enter the Brain in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT02348216 Study Evaluating the Safety and Efficacy of KTE-C19 in Adult Participants With Refractory Aggressive Non-Hodgkin Lymphoma Status COMPLETED Phase PHASE1/PHASE2
NCT02334722 1 Week Versus 6 Weeks of Levetiracetam in Surgical Brain Tumor Patients Status COMPLETED Phase PHASE4
NCT02208492 The Effects on Cognitive Function of Levetiracetam (Keppra®) Compared to Carbamazepine (Tegretol®, Carmazepine®) as Monotherapy for Children With Partial Seizure; A Multicentric Randomized Controlled Study Status COMPLETED Phase PHASE4
NCT02201251 A Study to Investigate the Safety of the Drugs Topiramate and Levetiracetam in Treating Children Recently Diagnosed With Epilepsy Status COMPLETED Phase PHASE3
NCT02199509 Efficacy of Levetiracetam in Oromandibular and Cranial Dystonia Status COMPLETED Phase PHASE2
NCT02002819 Levetiracetam for Alzheimer's Disease-Associated Network Hyperexcitability Status COMPLETED Phase PHASE2
NCT01954121 Open-label, Randomized, Active-controlled Study of LEV Used as Monotherapy in Patients With Partial-Onset Seizures Status COMPLETED Phase PHASE3